Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 3/20 | 0.58 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.56 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.54 |
| ▸ | DRD4 | P21917 | 4/20 | 0.51 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.49 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | HTR3A | P46098 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7724269 | 1.00 | CHRNA7 (0.58) | CHRNA7SIGMAR1CXCR3DRD4CHRM2 | |
| SCHEMBL7729420 | 0.90 | MEN1 (0.49) | CHRNA7SIGMAR1DRD4CHRM2CHRM1 | |
| SCHEMBL7729426 | 0.90 | MEN1 (0.49) | CHRNA7SIGMAR1DRD4CHRM2CHRM1 | |
| SCHEMBL7723196 | 0.84 | SIGMAR1 (0.56) | SIGMAR1CXCR3DRD4DRD2HTR2A | |
| SCHEMBL7723197 | 0.84 | SIGMAR1 (0.56) | SIGMAR1CXCR3DRD4DRD2HTR2A | |
| SCHEMBL7723192 | 0.84 | SIGMAR1 (0.56) | SIGMAR1CXCR3DRD4DRD2HTR2A | |
| SCHEMBL7719805 | 0.81 | SIGMAR1 (0.51) | SIGMAR1CXCR3DRD4DRD2DRD3 | |
| SCHEMBL12614464 | 0.79 | CHRNA7 (0.68) | CHRNA7DRD4CHRM2CHRM1CHRM3 | |
| SCHEMBL7729583 | 0.78 | SIGMAR1 (0.55) | SIGMAR1CXCR3DRD4DRD2HTR2A | |
| SCHEMBL7729579 | 0.78 | SIGMAR1 (0.55) | SIGMAR1CXCR3DRD4DRD2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6468998-B1 | ANTAGONIZE SEROTONIN 2 RECEPTORS, SUPPRESS PLATELET AGGREGATION, IMPROVE PERIPHERAL CIRCULATION AND PROMOTE LACHRYMATION | MITSUBISHI PHARMA CORPORATION (JP) | 2002-10-22 | — | — | US | disclosed |
| EP-1125922-A1 | PYRROLIDINE COMPOUNDS AND MEDICINAL UTILIZATION THEREOF | Welfide Corporation (JP) | 2001-08-22 | — | — | EP | disclosed |